The RAPS learning platform provider will be upgrading its security posture. This will take the system off-line from 20 July through the end of the day 23 July. This will affect any Online Course, eBook, and Virtual Program Attendance. Thank you for your patience.
Science & Technology: FDA Requirements for New Molecular Entities for the Treatment of Cancer
Posted 01 July 2011 | By
New products for cancer indications are often approved by the US Food and Drug Administration (FDA) based on fewer and smaller clinical studies containing a smaller percentage of US patients than treatments for other diseases. For most products used to treat other diseases, FDA usually requires that New Drug Applications (NDAs) have at least two controlled clinical trials.